Key highlights: Average weight loss of ~12.4% in Phase 3 trials Improvements in blood pressure, triglycerides, and waist circumference Oral formulation could significantly expand accessibility and patient adoption Approved for adults with obesity or overweight plus weight-related conditions This approval represents another major shift in the rapidly growing obesity therapeutics market and increases competition with injectable treatments like Wegovy
They are often used in combination with other hypoglycemic agents like glycosidase inhibitors or insulin for better blood glucose management
When you take a GLP-1 medication, it can help you feel fuller longer, slow down how quickly food leaves your stomach, and support more stable blood sugar levels
Because appetite suppression makes eating less appealing, patients may unintentionally skip hydration or protein intake, both essential for sustained energy
Bezerra FSB, Silva MTO, Rezende AFS, Lopes AS, de Pinho RB, Seixas FK, Collares TV, Portela RWD, Azevedo VAC, Borsuk S (2021) Saponin-adjuvanted recombinant vaccines containing rCP00660, rCP09720 or rCP01850 proteins against Corynebacterium pseudotuberculosis infection in mice
Rare systemic effects have also been observed in experimental models